Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3510LO3W
Performance in the last:
Follow this Portfolio
1D 0.7 %
1W 4.4 %
2W 0.5 %
1M -0.3 %
3M -4.7 %
6M -6.6 %
9M -6.1 %
1Y -6.4 %
Alpha
-23.5%
Beta
0.75
sharpe-R
-0.12
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:40
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -22.26%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 10.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
PODD Insulet Corporation Equity Buy 11.35% 15.22%
ESPR Esperion Therapeutics, Inc. Equity Buy 8.74% -2.73%
NVCR NovoCure Limited Equity Buy 8.71% -0.17%
MYGN Myriad Genetics, Inc. Equity Buy 9.1% 6.04%
The percentage of cash held in the portfolio is: 62.11%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 11.32% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 8.68% -3.83%
NVCR NovoCure Limited Buy 8.72% -0.5%
MYGN Myriad Genetics, Inc. Buy 8.92% 3.45%
The percentage of cash held in the portfolio is: 62.37%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 10.3% 1.14%
PODD Insulet Corporation Buy 11.52% 12.73%
TVTX Travere Therapeutics, Inc. Buy 12.23% 31.25%
ESPR Esperion Therapeutics, Inc. Buy 8.91% -4.37%
NVCR NovoCure Limited Buy 8.69% -3.99%
MYGN Myriad Genetics, Inc. Buy 8.71% -2.15%
The percentage of cash held in the portfolio is: 39.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 10.59% 3.11%
AADI Aadi Bioscience, Inc. Buy 10.79% 5.14%
PODD Insulet Corporation Buy 11.47% 11.4%
TVTX Travere Therapeutics, Inc. Buy 11.97% 27.5%
ESPR Esperion Therapeutics, Inc. Buy 8.93% -4.92%
NVCR NovoCure Limited Buy 8.7% -4.54%
MYGN Myriad Genetics, Inc. Buy 8.74% -2.56%
The percentage of cash held in the portfolio is: 28.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.09% -1.69%
AGEN Agenus Inc. Buy 10.25% -0.18%
AADI Aadi Bioscience, Inc. Buy 10.43% 1.71%
PODD Insulet Corporation Buy 11.4% 10.8%
TVTX Travere Therapeutics, Inc. Buy 12.55% 33.75%
ESPR Esperion Therapeutics, Inc. Buy 8.87% -5.46%
NVCR NovoCure Limited Buy 8.53% -6.37%
MYGN Myriad Genetics, Inc. Buy 8.99% 0.26%
The percentage of cash held in the portfolio is: 18.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.29% 0.21%
CARA Cara Therapeutics, Inc. Buy 9.28% -9.62%
AGEN Agenus Inc. Buy 9.63% -6.22%
AADI Aadi Bioscience, Inc. Buy 10.61% 3.43%
PODD Insulet Corporation Buy 11.03% 7.2%
TVTX Travere Therapeutics, Inc. Buy 12.57% 33.96%
ESPR Esperion Therapeutics, Inc. Buy 8.71% -7.1%
NVCR NovoCure Limited Buy 8.38% -7.98%
MYGN Myriad Genetics, Inc. Buy 9.02% 0.63%
The percentage of cash held in the portfolio is: 10.49%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.73% 3%
CARA Cara Therapeutics, Inc. Buy 9.78% -6.12%
AGEN Agenus Inc. Buy 9.43% -9.51%
AADI Aadi Bioscience, Inc. Buy 10.89% 4.57%
PODD Insulet Corporation Buy 10.97% 5.05%
TVTX Travere Therapeutics, Inc. Buy 10.89% 14.37%
ESPR Esperion Therapeutics, Inc. Buy 8.59% -9.84%
ALDX Aldeyra Therapeutics, Inc. Buy 8.97% -3.01%
NVCR NovoCure Limited Buy 8.65% -6.48%
MYGN Myriad Genetics, Inc. Buy 9.1% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.24% -1.42%
ORGO Organogenesis Holdings Inc. Buy 9.69% -6.71%
CARA Cara Therapeutics, Inc. Buy 9.72% -6.41%
AGEN Agenus Inc. Buy 9.5% -8.59%
AADI Aadi Bioscience, Inc. Buy 10.67% 2.86%
PODD Insulet Corporation Buy 11.01% 5.72%
TVTX Travere Therapeutics, Inc. Buy 9.82% 3.44%
ESPR Esperion Therapeutics, Inc. Buy 8.92% -6.01%
ALDX Aldeyra Therapeutics, Inc. Buy 9.22% 0%
NVCR NovoCure Limited Buy 9.22% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 9.84% -5.21%
ORGO Organogenesis Holdings Inc. Buy 9.91% -4.59%
CARA Cara Therapeutics, Inc. Buy 9.75% -6.12%
AGEN Agenus Inc. Buy 9.21% -11.33%
AADI Aadi Bioscience, Inc. Buy 10.67% 2.86%
PODD Insulet Corporation Buy 10.82% 3.96%
TVTX Travere Therapeutics, Inc. Buy 9.93% 4.69%
ESPR Esperion Therapeutics, Inc. Buy 9.44% -0.55%
ALDX Aldeyra Therapeutics, Inc. Buy 9.21% 0%
The percentage of cash held in the portfolio is: 11.21%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 10.08% -2.65%
ORGO Organogenesis Holdings Inc. Buy 9.99% -3.53%
CARA Cara Therapeutics, Inc. Buy 10% -3.5%
AGEN Agenus Inc. Buy 9.38% -9.51%
CERS Cerus Corporation Buy 9.52% -7.98%
AADI Aadi Bioscience, Inc. Buy 10.29% -0.57%
PODD Insulet Corporation Buy 10.5% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.3% -10.38%
TVTX Travere Therapeutics, Inc. Buy 9.47% 0%
ESPR Esperion Therapeutics, Inc. Buy 9.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • TVTX
  • ESPR
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.64% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 9.57% -4.2%
ORGO Organogenesis Holdings Inc. Buy 10.34% 3.53%
CARA Cara Therapeutics, Inc. Buy 10.37% 3.79%
AGEN Agenus Inc. Buy 9.33% -6.58%
CERS Cerus Corporation Buy 9.39% -5.88%
AADI Aadi Bioscience, Inc. Buy 9.58% -4%
NEOG Neogen Corporation Buy 9.77% -2.15%
PODD Insulet Corporation Buy 10.01% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.55% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -0.64%
ORGO Organogenesis Holdings Inc. Buy 10.16% 3.89%
CARA Cara Therapeutics, Inc. Buy 10.24% 4.66%
AGEN Agenus Inc. Buy 10.07% 2.93%
CERS Cerus Corporation Buy 9.53% -2.52%
AADI Aadi Bioscience, Inc. Buy 9.38% -4%
NEOG Neogen Corporation Buy 9.78% 0%
The percentage of cash held in the portfolio is: 21.57%
New Assets Added
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.51% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 9.6% -0.05%
ORGO Organogenesis Holdings Inc. Buy 10.28% 7.07%
CARA Cara Therapeutics, Inc. Buy 10.36% 7.87%
AGEN Agenus Inc. Buy 10.3% 7.31%
CERS Cerus Corporation Buy 9.59% 0%
AADI Aadi Bioscience, Inc. Buy 9.59% 0%
The percentage of cash held in the portfolio is: 30.77%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.4% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 9.72% -1.79%
ORGO Organogenesis Holdings Inc. Buy 9.61% -2.83%
CARA Cara Therapeutics, Inc. Buy 9.9% 0%
AGEN Agenus Inc. Buy 9.9% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 9.8% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 9.8% 0%
ORGO Organogenesis Holdings Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 70.6%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -1.57%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 9.14% -7.66%
The percentage of cash held in the portfolio is: 90.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
RCM Sell All 7.14%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.53% 7.06%
CYH Community Health Systems, Inc. Buy 9.33% -5.3%
RMD ResMed Inc. Buy 9.11% 3.67%
The percentage of cash held in the portfolio is: 72.03%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All -5.42%
FATE Sell All 7.71%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 12.18% -1.06%
FATE Fate Therapeutics, Inc. Buy 14.65% 19.02%
RCM R1 RCM Inc. Buy 9.35% 7.83%
CYH Community Health Systems, Inc. Buy 9.4% -1.96%
RMD ResMed Inc. Buy 9.2% 7.5%
The percentage of cash held in the portfolio is: 45.23%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All -11.82%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 12.19% 2.25%
FATE Fate Therapeutics, Inc. Buy 16.33% 37.02%
RCM R1 RCM Inc. Buy 8.3% -1.15%
CYH Community Health Systems, Inc. Buy 9.6% 3.34%
HQY HealthEquity, Inc. Buy 9.01% -3.09%
HCSG Healthcare Services Group, Inc. Buy 8.44% -1.12%
RMD ResMed Inc. Buy 8.49% 2.5%
The percentage of cash held in the portfolio is: 27.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All 1.14%
OPK Sell All 7.58%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.26% -1.7%
OPK OPKO Health, Inc. Buy 9.1% 8.33%
BKD Brookdale Senior Living Inc. Buy 12.45% 3.44%
FATE Fate Therapeutics, Inc. Buy 15.88% 31.88%
RCM R1 RCM Inc. Buy 8.39% -1%
CYH Community Health Systems, Inc. Buy 9.51% 1.38%
HQY HealthEquity, Inc. Buy 9.09% -3.16%
HCSG Healthcare Services Group, Inc. Buy 8.58% -0.43%
RMD ResMed Inc. Buy 8.37% 0%
The percentage of cash held in the portfolio is: 10.37%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.86% 8.52%
OPK OPKO Health, Inc. Buy 8.84% 8.33%
BKD Brookdale Senior Living Inc. Buy 12.2% 4.37%
FATE Fate Therapeutics, Inc. Buy 16.26% 39.07%
RCM R1 RCM Inc. Buy 8.02% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 8.6% -4.26%
SMTI Sanara MedTech Inc. Buy 8.62% -5.45%
CYH Community Health Systems, Inc. Buy 9.27% 1.77%
HQY HealthEquity, Inc. Buy 8.96% -1.69%
HCSG Healthcare Services Group, Inc. Buy 8.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.8% 10.23%
OPK OPKO Health, Inc. Buy 8.95% 12.12%
BKD Brookdale Senior Living Inc. Buy 12.09% 5.69%
FATE Fate Therapeutics, Inc. Buy 15.99% 39.85%
RCM R1 RCM Inc. Buy 8.04% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 8.46% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 8.93% 1.6%
SMTI Sanara MedTech Inc. Buy 8.91% 0%
CYH Community Health Systems, Inc. Buy 8.91% 0%
HQY HealthEquity, Inc. Buy 8.91% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SMTI
  • CYH
  • HQY
Assets Removed
Asset Action Perf %
ATRC Sell All -12.65%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.93% 11.93%
OPK OPKO Health, Inc. Buy 8.58% 7.58%
BKD Brookdale Senior Living Inc. Buy 11.82% 3.44%
FATE Fate Therapeutics, Inc. Buy 15.87% 38.82%
ATRC AtriCure, Inc. Buy 9.75% -7%
RCM R1 RCM Inc. Buy 7.98% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 8.72% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 8.78% 0%
The percentage of cash held in the portfolio is: 19.57%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 8.58% 6.96%
OPK OPKO Health, Inc. Buy 8.63% 7.58%
BKD Brookdale Senior Living Inc. Buy 11.93% 3.7%
FATE Fate Therapeutics, Inc. Buy 15.31% 33.16%
ATRC AtriCure, Inc. Buy 10% -5.18%
RCM R1 RCM Inc. Buy 8.17% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 8.84% 0%
The percentage of cash held in the portfolio is: 28.53%
New Assets Added
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.01% 10.8%
OPK OPKO Health, Inc. Buy 9% 10.61%
BKD Brookdale Senior Living Inc. Buy 11.98% 2.78%
FATE Fate Therapeutics, Inc. Buy 13.67% 17.22%
ATRC AtriCure, Inc. Buy 10.07% -5.85%
RCM R1 RCM Inc. Buy 8.39% 2.15%
The percentage of cash held in the portfolio is: 37.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 13.4%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 10.24% 9.54%
PDSB PDS Biotechnology Corporation Buy 9.05% 9.94%
OPK OPKO Health, Inc. Buy 9.29% 12.88%
BKD Brookdale Senior Living Inc. Buy 11.94% 1.19%
FATE Fate Therapeutics, Inc. Buy 12.95% 9.77%
ATRC AtriCure, Inc. Buy 10.33% -4.47%
RCM R1 RCM Inc. Buy 8.47% 2%
The percentage of cash held in the portfolio is: 27.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALT Sell All -16.04%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRDN Viridian Therapeutics, Inc. Buy 10.18% 9.54%
PDSB PDS Biotechnology Corporation Buy 8.98% 9.66%
ALT Altimmune, Inc. Buy 7.17% -12.43%
OPK OPKO Health, Inc. Buy 9.43% 15.15%
BKD Brookdale Senior Living Inc. Buy 11.92% 1.59%
FATE Fate Therapeutics, Inc. Buy 13% 10.8%
ATRC AtriCure, Inc. Buy 10.49% -2.49%
RCM R1 RCM Inc. Buy 8.14% -1.46%
The percentage of cash held in the portfolio is: 20.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All 17.81%
WST Sell All -5.09%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.12% 23.12%
VRDN Viridian Therapeutics, Inc. Buy 10.43% 15.37%
PDSB PDS Biotechnology Corporation Buy 9.07% 13.92%
ALT Altimmune, Inc. Buy 7.97% 0.13%
OPK OPKO Health, Inc. Buy 8.56% 7.58%
WST West Pharmaceutical Services, Inc. Buy 7.73% -1.88%
BKD Brookdale Senior Living Inc. Buy 11.66% 2.25%
FATE Fate Therapeutics, Inc. Buy 13.07% 14.65%
ATRC AtriCure, Inc. Buy 10.36% -0.91%
RCM R1 RCM Inc. Buy 8.03% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
Assets Removed
Asset Action Perf %
BHVN Sell All 0.3%
Assets Rebalanced
None
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 11.03% 25%
VRDN Viridian Therapeutics, Inc. Buy 10.67% 20.89%
PDSB PDS Biotechnology Corporation Buy 9.15% 17.76%
BHVN Biohaven Ltd. Buy 8.15% 4.86%
ALT Altimmune, Inc. Buy 8.42% 8.29%
OPK OPKO Health, Inc. Buy 8.48% 9.09%
WST West Pharmaceutical Services, Inc. Buy 7.6% -1.26%
BKD Brookdale Senior Living Inc. Buy 11.24% 0.93%
FATE Fate Therapeutics, Inc. Buy 13.03% 16.97%
ATRC AtriCure, Inc. Buy 10.21% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ATRC
Assets Removed
Asset Action Perf %
RARE Sell All 13.6%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
RARE Ultragenyx Pharmaceutical Inc. Buy 10.47% 11.57%
CYH Community Health Systems, Inc. Buy 11.15% 21.88%
VRDN Viridian Therapeutics, Inc. Buy 10.17% 11.2%
PDSB PDS Biotechnology Corporation Buy 9.67% 20.03%
BHVN Biohaven Ltd. Buy 8.56% 6.27%
ALT Altimmune, Inc. Buy 8.51% 5.61%
OPK OPKO Health, Inc. Buy 8.73% 8.33%
WST West Pharmaceutical Services, Inc. Buy 7.66% -3.96%
BKD Brookdale Senior Living Inc. Buy 11.54% 0%
FATE Fate Therapeutics, Inc. Buy 11.54% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BKD
  • FATE
Assets Removed
Asset Action Perf %
ACAD Sell All 13.54%
EGRX Sell All 33.26%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.77% 11.15%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.04% 34.6%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.67% 10.14%
CYH Community Health Systems, Inc. Buy 10.95% 15.94%
VRDN Viridian Therapeutics, Inc. Buy 9.26% -1.97%
PDSB PDS Biotechnology Corporation Buy 9.17% 10.23%
BHVN Biohaven Ltd. Buy 8.73% 4.89%
ALT Altimmune, Inc. Buy 8.54% 2.67%
OPK OPKO Health, Inc. Buy 8.63% 3.79%
WST West Pharmaceutical Services, Inc. Buy 8.24% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • WST
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.87% 7.75%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.61% 34.82%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.76% 6.55%
CYH Community Health Systems, Inc. Buy 10.27% 4.37%
VRDN Viridian Therapeutics, Inc. Buy 9.14% -7.12%
PDSB PDS Biotechnology Corporation Buy 8.67% 0%
BHVN Biohaven Ltd. Buy 8.67% 0%
ALT Altimmune, Inc. Buy 8.67% 0%
OPK OPKO Health, Inc. Buy 8.67% 0%
The percentage of cash held in the portfolio is: 10.67%
New Assets Added
  • PDSB
  • BHVN
  • ALT
  • OPK
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.89% 7.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 13.67% 35.49%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.7% 6.02%
CYH Community Health Systems, Inc. Buy 10.21% 3.75%
VRDN Viridian Therapeutics, Inc. Buy 9.2% -6.59%
The percentage of cash held in the portfolio is: 45.34%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVRO Sell All -11.61%
Assets Rebalanced
None
2024-07-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.09% -1.83%
EGRX Eagle Pharmaceuticals, Inc. Buy 12.62% 22.77%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.37% 0.9%
CYH Community Health Systems, Inc. Buy 10.55% 5.31%
NVRO Nevro Corp. Buy 9.76% -2.67%
VRDN Viridian Therapeutics, Inc. Buy 9.3% -7.27%
The percentage of cash held in the portfolio is: 37.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Sell All 1.87%
Assets Rebalanced
None
2024-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 10.23% -0.25%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.98% 16.74%
STAA STAAR Surgical Company Buy 10.8% 5.2%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.55% 2.79%
CYH Community Health Systems, Inc. Buy 10.72% 7.19%
NVRO Nevro Corp. Buy 9.71% -3.02%
VRDN Viridian Therapeutics, Inc. Buy 9.21% -7.95%
The percentage of cash held in the portfolio is: 26.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All -19.65%
MNKD Sell All -7.37%
ARDX Sell All -28.74%
Assets Rebalanced
None
2024-07-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.71% 1.01%
MNKD MannKind Corporation Buy 9.01% -6.26%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.86% 23.44%
STAA STAAR Surgical Company Buy 10.77% 12.05%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.92% 3.19%
CYH Community Health Systems, Inc. Buy 9.72% 3.75%
ARDX Ardelyx, Inc. Buy 9.56% 2.16%
CHRS Coherus BioSciences, Inc. Buy 8.71% -6.94%
NVRO Nevro Corp. Buy 9.37% 0%
VRDN Viridian Therapeutics, Inc. Buy 9.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVRO
  • VRDN
Assets Removed
None
Assets Rebalanced
None
2024-07-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.72% 2.33%
MNKD MannKind Corporation Buy 9.14% -3.87%
EGRX Eagle Pharmaceuticals, Inc. Buy 11.88% 25%
STAA STAAR Surgical Company Buy 10.69% 12.5%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.8% 3.14%
CYH Community Health Systems, Inc. Buy 9.73% 5%
ARDX Ardelyx, Inc. Buy 9.26% 0%
CHRS Coherus BioSciences, Inc. Buy 9.26% 0%
The percentage of cash held in the portfolio is: 20.52%
New Assets Added
  • ARDX
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.96% 3.09%
MNKD MannKind Corporation Buy 9.41% -2.58%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.82% 12.05%
STAA STAAR Surgical Company Buy 10.68% 10.52%
RARE Ultragenyx Pharmaceutical Inc. Buy 10.04% 3.94%
CYH Community Health Systems, Inc. Buy 9.42% 0%
The percentage of cash held in the portfolio is: 39.67%
New Assets Added
  • CYH
Assets Removed
None
Assets Rebalanced
None
2024-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.56% -2.39%
MNKD MannKind Corporation Buy 9.37% -4.42%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.76% 9.82%
STAA STAAR Surgical Company Buy 10.54% 7.54%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.97% 1.71%
The percentage of cash held in the portfolio is: 49.8%
New Assets Added
None
Assets Removed
Asset Action Perf %
FGEN Sell All -12.08%
Assets Rebalanced
None
2024-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.69% -1.76%
MNKD MannKind Corporation Buy 9.51% -3.5%
FGEN FibroGen, Inc. Buy 9.61% -2.5%
EGRX Eagle Pharmaceuticals, Inc. Buy 10.01% 1.56%
STAA STAAR Surgical Company Buy 9.86% 0%
RARE Ultragenyx Pharmaceutical Inc. Buy 9.86% 0%
The percentage of cash held in the portfolio is: 41.45%
New Assets Added
  • STAA
  • RARE
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ACAD ACADIA Pharmaceuticals Inc. Buy 9.8% 0%
MNKD MannKind Corporation Buy 9.8% 0%
FGEN FibroGen, Inc. Buy 9.8% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • ACAD
  • MNKD
  • FGEN
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-05-27 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
OMCL Sell All 8.3%
Assets Rebalanced
None
2024-05-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 11.36% 5.21%
The percentage of cash held in the portfolio is: 88.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -7.38%
Assets Rebalanced
None
2024-05-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
OMCL Omnicell, Inc. Buy 11.5% 7%
VCYT Veracyte, Inc. Buy 8.95% -3.91%
The percentage of cash held in the portfolio is: 79.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All -2.32%
INGN Sell All 22.55%
ACRS Sell All -8.73%
SGMO Sell All 18.52%
Assets Rebalanced
None
2024-05-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
INGN Inogen, Inc. Buy 11.65% 22.13%
ACRS Aclaris Therapeutics, Inc. Buy 8.93% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 10.6% 11.11%
OMCL Omnicell, Inc. Buy 11.44% 5.91%
VCYT Veracyte, Inc. Buy 9.06% -3.2%
PODD Insulet Corporation Buy 8.38% -1.4%
The percentage of cash held in the portfolio is: 39.94%
New Assets Added
None
Assets Removed
Asset Action Perf %
SENS Sell All -3.49%
Assets Rebalanced
None
2024-05-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
SENS Senseonics Holdings, Inc. Buy 9.17% -3.7%
INGN Inogen, Inc. Buy 11.82% 24.26%
ACRS Aclaris Therapeutics, Inc. Buy 8.98% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 10.74% 12.96%
OMCL Omnicell, Inc. Buy 10.98% 1.99%
VCYT Veracyte, Inc. Buy 9.25% -0.89%
PODD Insulet Corporation Buy 8.42% -0.67%
The percentage of cash held in the portfolio is: 30.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -0.79%
Assets Rebalanced
None
2024-05-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
CARA Cara Therapeutics, Inc. Buy 9.32% -0.79%
SENS Senseonics Holdings, Inc. Buy 9.36% -0.41%
INGN Inogen, Inc. Buy 11.75% 25.25%
ACRS Aclaris Therapeutics, Inc. Buy 8.86% -5.56%
SGMO Sangamo Therapeutics, Inc. Buy 11.29% 20.37%
OMCL Omnicell, Inc. Buy 10.73% 1.03%
VCYT Veracyte, Inc. Buy 9.36% 1.69%
PODD Insulet Corporation Buy 8.44% 1.02%
The percentage of cash held in the portfolio is: 20.9%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Sell All -14.91%
PTCT Sell All 15.84%
Assets Rebalanced
None
2024-05-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.06% 19.11%
IBRX ImmunityBio, Inc. Buy 8% -13.79%
CARA Cara Therapeutics, Inc. Buy 9.88% 6.48%
SENS Senseonics Holdings, Inc. Buy 9.38% 1.03%
INGN Inogen, Inc. Buy 11.77% 26.95%
ACRS Aclaris Therapeutics, Inc. Buy 8.68% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 10.47% 12.96%
OMCL Omnicell, Inc. Buy 11.03% 5.08%
VCYT Veracyte, Inc. Buy 9.46% 4%
PODD Insulet Corporation Buy 8.26% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PODD
Assets Removed
Asset Action Perf %
MD Sell All -8.68%
Assets Rebalanced
None
2024-05-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.57% 10.96%
IBRX ImmunityBio, Inc. Buy 9.14% -4%
CARA Cara Therapeutics, Inc. Buy 9.45% -0.79%
SENS Senseonics Holdings, Inc. Buy 8.68% -8.83%
INGN Inogen, Inc. Buy 11.89% 25.04%
ACRS Aclaris Therapeutics, Inc. Buy 8.91% -6.35%
SGMO Sangamo Therapeutics, Inc. Buy 9.69% 1.85%
OMCL Omnicell, Inc. Buy 11.01% 2.22%
MD Pediatrix Medical Group, Inc. Buy 9.34% 0%
VCYT Veracyte, Inc. Buy 9.34% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MD
  • VCYT
Assets Removed
None
Assets Rebalanced
None
2024-05-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.86% 12.88%
IBRX ImmunityBio, Inc. Buy 8.68% -9.68%
CARA Cara Therapeutics, Inc. Buy 9.11% -5.29%
SENS Senseonics Holdings, Inc. Buy 9.2% -4.31%
INGN Inogen, Inc. Buy 11.53% 20%
ACRS Aclaris Therapeutics, Inc. Buy 8.92% -7.14%
SGMO Sangamo Therapeutics, Inc. Buy 9.96% 3.7%
OMCL Omnicell, Inc. Buy 10.87% -0.03%
The percentage of cash held in the portfolio is: 20.88%
New Assets Added
None
Assets Removed
Asset Action Perf %
IOVA Sell All -12.24%
Assets Rebalanced
None
2024-05-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.21% 8.68%
IBRX ImmunityBio, Inc. Buy 8.42% -10.34%
CARA Cara Therapeutics, Inc. Buy 9.44% 0.53%
SENS Senseonics Holdings, Inc. Buy 9.28% -1.23%
INGN Inogen, Inc. Buy 11.57% 23.26%
ACRS Aclaris Therapeutics, Inc. Buy 9.12% -2.78%
IOVA Iovance Biotherapeutics, Inc. Buy 10.1% 7.6%
SGMO Sangamo Therapeutics, Inc. Buy 9.04% -3.7%
OMCL Omnicell, Inc. Buy 10.66% 0.4%
The percentage of cash held in the portfolio is: 12.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Sell All 7.67%
Assets Rebalanced
None
2024-05-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.61% 15.54%
IBRX ImmunityBio, Inc. Buy 9.35% 1.78%
CDMO Avid Bioservices, Inc. Buy 10.02% 9.13%
CARA Cara Therapeutics, Inc. Buy 9.45% 2.94%
SENS Senseonics Holdings, Inc. Buy 9.53% 3.68%
INGN Inogen, Inc. Buy 9.3% 1.42%
ACRS Aclaris Therapeutics, Inc. Buy 9.9% 7.94%
IOVA Iovance Biotherapeutics, Inc. Buy 10% 9.04%
SGMO Sangamo Therapeutics, Inc. Buy 9.44% 2.93%
OMCL Omnicell, Inc. Buy 10.38% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OMCL
Assets Removed
Asset Action Perf %
SMMT Sell All 13.73%
Assets Rebalanced
None
2024-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 11.35% 19.57%
SMMT Summit Therapeutics Inc. Buy 11.56% 21.76%
IBRX ImmunityBio, Inc. Buy 9.01% -5.01%
CDMO Avid Bioservices, Inc. Buy 9.63% 1.46%
CARA Cara Therapeutics, Inc. Buy 9.53% 0.4%
SENS Senseonics Holdings, Inc. Buy 9.02% -4.93%
INGN Inogen, Inc. Buy 9.48% 0%
ACRS Aclaris Therapeutics, Inc. Buy 9.48% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 9.48% 0%
SGMO Sangamo Therapeutics, Inc. Buy 9.48% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INGN
  • ACRS
  • IOVA
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-05-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.99% 12.53%
SMMT Summit Therapeutics Inc. Buy 9.94% 1.81%
IBRX ImmunityBio, Inc. Buy 8.68% -11.12%
CDMO Avid Bioservices, Inc. Buy 9.85% 0.93%
CARA Cara Therapeutics, Inc. Buy 9.71% -0.53%
SENS Senseonics Holdings, Inc. Buy 9.77% 0%
The percentage of cash held in the portfolio is: 41.06%
New Assets Added
  • SENS
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 10.89% 12.5%
SMMT Summit Therapeutics Inc. Buy 9.73% 0.52%
IBRX ImmunityBio, Inc. Buy 9.67% 0%
CDMO Avid Bioservices, Inc. Buy 9.67% 0%
CARA Cara Therapeutics, Inc. Buy 9.67% 0%
The percentage of cash held in the portfolio is: 50.37%
New Assets Added
  • IBRX
  • CDMO
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTCT PTC Therapeutics, Inc. Buy 9.8% 0%
SMMT Summit Therapeutics Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • PTCT
  • SMMT
Assets Removed
None
Assets Rebalanced
None
2024-04-23 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All -6.11%
Assets Rebalanced
None
2024-04-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 9.41% -4.58%
The percentage of cash held in the portfolio is: 90.59%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANGO Sell All 11.05%
KIDS Sell All 3.21%
ACRS Sell All -2.38%
Assets Rebalanced
None
2024-04-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.48% 10.7%
KIDS OrthoPediatrics Corp. Buy 10.9% 5.11%
ACRS Aclaris Therapeutics, Inc. Buy 9.96% -3.97%
OPK OPKO Health, Inc. Buy 9.27% -6.11%
The percentage of cash held in the portfolio is: 58.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -9.75%
Assets Rebalanced
None
2024-04-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.5% 11.75%
TNDM Tandem Diabetes Care, Inc. Buy 9.76% -5.1%
KIDS OrthoPediatrics Corp. Buy 11.04% 7.32%
ACRS Aclaris Therapeutics, Inc. Buy 9.88% -3.97%
OPK OPKO Health, Inc. Buy 9.2% -6.11%
The percentage of cash held in the portfolio is: 48.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Sell All -16.06%
Assets Rebalanced
None
2024-04-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 12.13% 20.18%
TNDM Tandem Diabetes Care, Inc. Buy 9.89% -2.07%
KIDS OrthoPediatrics Corp. Buy 11.07% 9.67%
ACRS Aclaris Therapeutics, Inc. Buy 9.29% -7.94%
RVNC Revance Therapeutics, Inc. Buy 9.05% -10.37%
OPK OPKO Health, Inc. Buy 9.32% -3.05%
The percentage of cash held in the portfolio is: 39.25%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Sell All -15.83%
Assets Rebalanced
None
2024-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 11.09% 8.6%
TNDM Tandem Diabetes Care, Inc. Buy 9.69% -5.1%
KIDS OrthoPediatrics Corp. Buy 9.41% -7.9%
ACRS Aclaris Therapeutics, Inc. Buy 9.89% -3.17%
RVNC Revance Therapeutics, Inc. Buy 9.36% -8.33%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.4% -7.92%
OPK OPKO Health, Inc. Buy 10.02% 3.05%
The percentage of cash held in the portfolio is: 31.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
VCYT Sell All -5.57%
Assets Rebalanced
None
2024-04-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.31% 2.28%
TNDM Tandem Diabetes Care, Inc. Buy 9.67% -4.11%
KIDS OrthoPediatrics Corp. Buy 9.81% -2.69%
ACRS Aclaris Therapeutics, Inc. Buy 10.08% 0%
VCYT Veracyte, Inc. Buy 10.05% -0.37%
RVNC Revance Therapeutics, Inc. Buy 9.69% -3.86%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.58% -5%
OPK OPKO Health, Inc. Buy 9.6% 0%
The percentage of cash held in the portfolio is: 21.2%
New Assets Added
  • OPK
Assets Removed
Asset Action Perf %
OFIX Sell All -3.17%
ATRI Sell All -11.81%
Assets Rebalanced
None
2024-03-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 10.05% 2.98%
TNDM Tandem Diabetes Care, Inc. Buy 9.79% 0.31%
KIDS OrthoPediatrics Corp. Buy 9.82% 0.66%
ACRS Aclaris Therapeutics, Inc. Buy 9.6% -1.59%
VCYT Veracyte, Inc. Buy 9.96% 2.03%
ATRI Atrion Corporation Buy 9.76% 0%
OFIX Orthofix Medical Inc. Buy 9.76% 0%
RVNC Revance Therapeutics, Inc. Buy 9.76% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.76% 0%
The percentage of cash held in the portfolio is: 11.76%
New Assets Added
  • ATRI
  • OFIX
  • RVNC
  • LXRX
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 9.8% 0%
TNDM Tandem Diabetes Care, Inc. Buy 9.8% 0%
KIDS OrthoPediatrics Corp. Buy 9.8% 0%
ACRS Aclaris Therapeutics, Inc. Buy 9.8% 0%
VCYT Veracyte, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 51%
New Assets Added
  • ANGO
  • TNDM
  • KIDS
  • ACRS
  • VCYT
Assets Removed
Asset Action Perf %
BAX Sell All -0.7%
OMCL Sell All 5.22%
Assets Rebalanced
None
2024-03-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
BAX Baxter International Inc. Buy 10.14% -2.44%
OMCL Omnicell, Inc. Buy 10.44% 0.5%
The percentage of cash held in the portfolio is: 79.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 8.23%
RDNT Sell All 8.32%
NTRA Sell All 3.25%
Assets Rebalanced
None
2024-03-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 10.47% 8.8%
RDNT RadNet, Inc. Buy 10.25% 6.45%
NTRA Natera, Inc. Buy 10% 3.9%
BAX Baxter International Inc. Buy 10.12% -2.7%
OMCL Omnicell, Inc. Buy 10.45% 0.5%
The percentage of cash held in the portfolio is: 48.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
QTRX Sell All -9.55%
Assets Rebalanced
None
2024-03-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 10.34% 6.46%
RDNT RadNet, Inc. Buy 9.82% 1.08%
NTRA Natera, Inc. Buy 9.79% 0.79%
QTRX Quanterix Corporation Buy 7.84% -5.31%
BAX Baxter International Inc. Buy 10.14% -3.37%
OMCL Omnicell, Inc. Buy 10.38% -1.15%
The percentage of cash held in the portfolio is: 41.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
ABUS Sell All -5.93%
Assets Rebalanced
None
2024-03-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 10.16% 4.78%
RDNT RadNet, Inc. Buy 9.72% 0.23%
NTRA Natera, Inc. Buy 9.71% 0.12%
QTRX Quanterix Corporation Buy 7.81% -5.42%
BAX Baxter International Inc. Buy 10.14% -3.21%
OMCL Omnicell, Inc. Buy 10.44% -0.36%
ABUS Arbutus Biopharma Corporation Buy 12.29% -2.96%
The percentage of cash held in the portfolio is: 29.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTGX Sell All 1.76%
Assets Rebalanced
None
2024-03-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 10.06% -0.46%
THC Tenet Healthcare Corporation Buy 10.34% 6.1%
RDNT RadNet, Inc. Buy 9.64% -1.08%
NTRA Natera, Inc. Buy 9.56% -1.9%
QTRX Quanterix Corporation Buy 7.8% -6.02%
BAX Baxter International Inc. Buy 10.29% -2.26%
OMCL Omnicell, Inc. Buy 10.45% -0.72%
ABUS Arbutus Biopharma Corporation Buy 12.3% -3.33%
The percentage of cash held in the portfolio is: 19.56%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -15.74%
Assets Rebalanced
None
2024-03-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 10.27% 4.88%
THC Tenet Healthcare Corporation Buy 10% 6.01%
MRSN Mersana Therapeutics, Inc. Buy 8.96% -5.05%
RDNT RadNet, Inc. Buy 9.79% 3.77%
NTRA Natera, Inc. Buy 9.58% 1.57%
QTRX Quanterix Corporation Buy 7.68% -4.49%
BAX Baxter International Inc. Buy 10.17% -0.23%
OMCL Omnicell, Inc. Buy 10.3% 1.04%
ABUS Arbutus Biopharma Corporation Buy 12.27% -0.37%
The percentage of cash held in the portfolio is: 10.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
ENTA Sell All -5.28%
Assets Rebalanced
None
2024-03-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 10.37% 8.46%
THC Tenet Healthcare Corporation Buy 9.59% 4.1%
MRSN Mersana Therapeutics, Inc. Buy 9.08% -1.52%
ENTA Enanta Pharmaceuticals, Inc. Buy 9.44% 2.41%
RDNT RadNet, Inc. Buy 10.09% 9.45%
NTRA Natera, Inc. Buy 9.45% 2.52%
QTRX Quanterix Corporation Buy 7.84% -0.07%
BAX Baxter International Inc. Buy 10.07% 1.16%
OMCL Omnicell, Inc. Buy 10.05% 0.97%
ABUS Arbutus Biopharma Corporation Buy 12.03% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ABUS
Assets Removed
Asset Action Perf %
RCM Sell All 27.04%
Assets Rebalanced
None
2024-03-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 11.9% 24.71%
PTGX Protagonist Therapeutics, Inc. Buy 10.57% 9.8%
THC Tenet Healthcare Corporation Buy 9.58% 3.23%
MRSN Mersana Therapeutics, Inc. Buy 8.97% -3.37%
ENTA Enanta Pharmaceuticals, Inc. Buy 9.47% 2.02%
RDNT RadNet, Inc. Buy 10.15% 9.36%
NTRA Natera, Inc. Buy 9.36% 0.91%
QTRX Quanterix Corporation Buy 7.96% 0.75%
BAX Baxter International Inc. Buy 10.02% 0%
OMCL Omnicell, Inc. Buy 10.02% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BAX
  • OMCL
Assets Removed
Asset Action Perf %
NUTX Sell All -12.3%
BRKR Sell All 13.09%
Assets Rebalanced
None
2024-03-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 9.34% -6.56%
BRKR Bruker Corporation Buy 11.24% 12.49%
RCM R1 RCM Inc. Buy 11.96% 25.25%
PTGX Protagonist Therapeutics, Inc. Buy 10.7% 11.13%
THC Tenet Healthcare Corporation Buy 9.23% -0.63%
MRSN Mersana Therapeutics, Inc. Buy 8.99% -3.2%
ENTA Enanta Pharmaceuticals, Inc. Buy 9.47% 1.95%
RDNT RadNet, Inc. Buy 9.81% 5.61%
NTRA Natera, Inc. Buy 9.37% 0.89%
QTRX Quanterix Corporation Buy 7.91% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • QTRX
Assets Removed
Asset Action Perf %
RVNC Sell All -14.99%
Assets Rebalanced
None
2024-03-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 9.2% -7.38%
BRKR Bruker Corporation Buy 10.95% 10.34%
RCM R1 RCM Inc. Buy 11.9% 25.34%
PTGX Protagonist Therapeutics, Inc. Buy 10.81% 12.89%
RVNC Revance Therapeutics, Inc. Buy 9.02% -2.24%
THC Tenet Healthcare Corporation Buy 9.23% 0%
MRSN Mersana Therapeutics, Inc. Buy 9.23% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 9.23% 0%
RDNT RadNet, Inc. Buy 9.23% 0%
NTRA Natera, Inc. Buy 9.23% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • THC
  • MRSN
  • ENTA
  • RDNT
  • NTRA
Assets Removed
None
Assets Rebalanced
None
2024-03-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 9.25% -7.38%
BRKR Bruker Corporation Buy 10.79% 8.11%
RCM R1 RCM Inc. Buy 12.01% 25.78%
PTGX Protagonist Therapeutics, Inc. Buy 10.27% 6.67%
RVNC Revance Therapeutics, Inc. Buy 9.28% 0%
The percentage of cash held in the portfolio is: 48.4%
New Assets Added
  • RVNC
Assets Removed
Asset Action Perf %
CARA Sell All 32.4%
NVAX Sell All 14.88%
VRDN Sell All -7.24%
Assets Rebalanced
None
2024-02-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 9.15% -8.2%
BRKR Bruker Corporation Buy 10.77% 8.03%
RCM R1 RCM Inc. Buy 12.28% 28.83%
NVAX Novavax, Inc. Buy 9.77% 2.56%
CARA Cara Therapeutics, Inc. Buy 11.03% 38.63%
PTGX Protagonist Therapeutics, Inc. Buy 10.27% 6.85%
VRDN Viridian Therapeutics, Inc. Buy 8.68% 0%
The percentage of cash held in the portfolio is: 28.05%
New Assets Added
  • VRDN
Assets Removed
Asset Action Perf %
CUTR Sell All -32.07%
RGNX Sell All 36.58%
INGN Sell All -38.03%
Assets Rebalanced
None
2024-02-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 11.69% 37.41%
NUTX Nutex Health Inc. Buy 8.39% -8.2%
BRKR Bruker Corporation Buy 9.56% 4.56%
CUTR Cutera, Inc. Buy 8.32% -8.97%
RCM R1 RCM Inc. Buy 11.41% 30.53%
INGN Inogen, Inc. Buy 8.04% -7.98%
NVAX Novavax, Inc. Buy 12.23% 40%
CARA Cara Therapeutics, Inc. Buy 10.76% 47.35%
PTGX Protagonist Therapeutics, Inc. Buy 9.16% 3.9%
The percentage of cash held in the portfolio is: 10.44%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATRI Sell All 0.86%
Assets Rebalanced
None
2024-02-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATRI Atrion Corporation Buy 9.19% 0.57%
RGNX REGENXBIO Inc. Buy 10.91% 19.49%
NUTX Nutex Health Inc. Buy 9.49% -3.28%
BRKR Bruker Corporation Buy 10.38% 5.77%
CUTR Cutera, Inc. Buy 8.12% -17.24%
RCM R1 RCM Inc. Buy 9.32% -0.63%
INGN Inogen, Inc. Buy 8.5% -9.46%
NVAX Novavax, Inc. Buy 11.54% 23.02%
CARA Cara Therapeutics, Inc. Buy 11.07% 41.28%
PTGX Protagonist Therapeutics, Inc. Buy 9.46% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
NTLA Sell All 3.2%
Assets Rebalanced
None
2024-02-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 10.27% 7.35%
ATRI Atrion Corporation Buy 9.66% 2.22%
RGNX REGENXBIO Inc. Buy 12.03% 27.25%
NUTX Nutex Health Inc. Buy 9.58% -5.74%
BRKR Bruker Corporation Buy 10.3% 1.31%
CUTR Cutera, Inc. Buy 10.27% 1.03%
RCM R1 RCM Inc. Buy 9.37% -3.58%
INGN Inogen, Inc. Buy 9.08% -6.5%
NVAX Novavax, Inc. Buy 9.33% -3.95%
CARA Cara Therapeutics, Inc. Buy 8.11% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
Assets Removed
Asset Action Perf %
MRSN Sell All -14.18%
Assets Rebalanced
None
2024-02-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 10.49% 12.57%
ATRI Atrion Corporation Buy 9.36% 1.57%
RGNX REGENXBIO Inc. Buy 11.67% 26.63%
MRSN Mersana Therapeutics, Inc. Buy 8.31% -9.22%
NUTX Nutex Health Inc. Buy 9.83% -0.82%
BRKR Bruker Corporation Buy 9.91% 0.06%
CUTR Cutera, Inc. Buy 10.01% 1.03%
RCM R1 RCM Inc. Buy 9.47% 0%
INGN Inogen, Inc. Buy 9.47% 0%
NVAX Novavax, Inc. Buy 9.47% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • RCM
  • INGN
  • NVAX
Assets Removed
Asset Action Perf %
AGEN Sell All -7.14%
Assets Rebalanced
None
2024-02-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
NTLA Intellia Therapeutics, Inc. Buy 10.23% 11.82%
ATRI Atrion Corporation Buy 8.72% -3.57%
AGEN Agenus Inc. Buy 11.99% 32.56%
RGNX REGENXBIO Inc. Buy 10.42% 15.24%
MRSN Mersana Therapeutics, Inc. Buy 8.05% -10.4%
NUTX Nutex Health Inc. Buy 9.72% 0%
BRKR Bruker Corporation Buy 9.72% 0%
CUTR Cutera, Inc. Buy 9.72% 0%
The percentage of cash held in the portfolio is: 21.44%
New Assets Added
  • NUTX
  • BRKR
  • CUTR
Assets Removed
Asset Action Perf %
LXRX Sell All 55.87%
Assets Rebalanced
None
2024-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 13.21% 37.56%
NTLA Intellia Therapeutics, Inc. Buy 10.04% 4.59%
ATRI Atrion Corporation Buy 9.3% -2.04%
AGEN Agenus Inc. Buy 10.31% 8.57%
RGNX REGENXBIO Inc. Buy 10.45% 10.09%
MRSN Mersana Therapeutics, Inc. Buy 8.54% -9.46%
The percentage of cash held in the portfolio is: 38.15%
New Assets Added
None
Assets Removed
Asset Action Perf %
ARCT Sell All 2.7%
SAVA Sell All -6.26%
SMTI Sell All -9.09%
CLDX Sell All -6.72%
Assets Rebalanced
None
2024-02-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.3% 7.98%
NTLA Intellia Therapeutics, Inc. Buy 10.36% 8.62%
ATRI Atrion Corporation Buy 9.97% 5.75%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.47% 0.42%
AGEN Agenus Inc. Buy 9.43% 0%
SMTI Sanara MedTech Inc. Buy 9.82% 4.06%
RGNX REGENXBIO Inc. Buy 10.55% 11.81%
CLDX Celldex Therapeutics, Inc. Buy 9.36% -0.77%
SAVA Cassava Sciences, Inc. Buy 9.38% -0.59%
MRSN Mersana Therapeutics, Inc. Buy 9.37% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2024-02-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.93% 0.94%
NTLA Intellia Therapeutics, Inc. Buy 10.14% 3.08%
ATRI Atrion Corporation Buy 10.27% 5.59%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.61% -1.19%
AGEN Agenus Inc. Buy 9.44% -2.86%
SMTI Sanara MedTech Inc. Buy 9.72% 0%
RGNX REGENXBIO Inc. Buy 9.72% 0%
CLDX Celldex Therapeutics, Inc. Buy 9.72% 0%
SAVA Cassava Sciences, Inc. Buy 9.72% 0%
The percentage of cash held in the portfolio is: 11.72%
New Assets Added
  • SMTI
  • RGNX
  • CLDX
  • SAVA
Assets Removed
None
Assets Rebalanced
None
2024-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 10.17% 3.76%
NTLA Intellia Therapeutics, Inc. Buy 10.3% 5.06%
ATRI Atrion Corporation Buy 9.69% 0%
ARCT Arcturus Therapeutics Holdings Inc. Buy 9.69% 0%
AGEN Agenus Inc. Buy 9.69% 0%
The percentage of cash held in the portfolio is: 50.46%
New Assets Added
  • ATRI
  • ARCT
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.57% -3.76%
NTLA Intellia Therapeutics, Inc. Buy 9.76% -1.78%
The percentage of cash held in the portfolio is: 80.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
PTGX Sell All -8.8%
Assets Rebalanced
None
2024-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 9.17% -7.12%
LXRX Lexicon Pharmaceuticals, Inc. Buy 9.87% 0%
NTLA Intellia Therapeutics, Inc. Buy 9.87% 0%
The percentage of cash held in the portfolio is: 71.09%
New Assets Added
  • LXRX
  • NTLA
Assets Removed
None
Assets Rebalanced
None
2024-02-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PTGX Protagonist Therapeutics, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • PTGX
Assets Removed
None
Assets Rebalanced
None
2023-12-08 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All 32.47%
Assets Rebalanced
None
2023-12-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
MRSN Mersana Therapeutics, Inc. Buy 14.99% 38.31%
The percentage of cash held in the portfolio is: 85.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -0.23%
SGRY Sell All 12.06%
AMEH Sell All -1.35%
Assets Rebalanced
None
2023-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 8.36% 1.48%
SGRY Surgery Partners, Inc. Buy 9.69% 17.66%
AMEH Apollo Medical Holdings, Inc. Buy 8.42% 2.23%
MRSN Mersana Therapeutics, Inc. Buy 14.32% 32.47%
The percentage of cash held in the portfolio is: 59.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
CBAY Sell All 20.69%
SENS Sell All 18.74%
Assets Rebalanced
None
2023-11-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
CBAY CymaBay Therapeutics, Inc. Buy 9.5% 6.11%
SENS Senseonics Holdings, Inc. Buy 9.53% 6.49%
NVCR NovoCure Limited Buy 8.32% -6.88%
SGRY Surgery Partners, Inc. Buy 9.72% 8.81%
AMEH Apollo Medical Holdings, Inc. Buy 8.76% -1.96%
MRSN Mersana Therapeutics, Inc. Buy 11.38% -2.92%
The percentage of cash held in the portfolio is: 42.78%
New Assets Added
None
Assets Removed
Asset Action Perf %
ISRG Sell All NA
RMD Sell All NA
THC Sell All NA
Assets Rebalanced
None
2023-11-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ISRG Intuitive Surgical, Inc. Buy 10.4% 13.64%
RMD ResMed Inc. Buy 9.31% 1.67%
THC Tenet Healthcare Corporation Buy 11.49% 25.52%
CBAY CymaBay Therapeutics, Inc. Buy 9.5% 6.11%
SENS Senseonics Holdings, Inc. Buy 9.53% 6.49%
NVCR NovoCure Limited Buy 8.32% -6.88%
SGRY Surgery Partners, Inc. Buy 9.72% 8.81%
AMEH Apollo Medical Holdings, Inc. Buy 8.76% -1.96%
MRSN Mersana Therapeutics, Inc. Buy 11.38% -2.92%
The percentage of cash held in the portfolio is: 11.58%
New Assets Added
None
Assets Removed
Asset Action Perf %
EW Sell All 5.06%
Assets Rebalanced
None
2023-11-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 9.87% 5.7%
ISRG Intuitive Surgical, Inc. Buy 10.2% 9.38%
RMD ResMed Inc. Buy 9.25% -0.8%
THC Tenet Healthcare Corporation Buy 10.05% 7.75%
CBAY CymaBay Therapeutics, Inc. Buy 9.84% 7.82%
SENS Senseonics Holdings, Inc. Buy 9.82% 7.57%
NVCR NovoCure Limited Buy 8.42% -7.58%
SGRY Surgery Partners, Inc. Buy 9.29% 2.02%
AMEH Apollo Medical Holdings, Inc. Buy 9.31% 2.26%
MRSN Mersana Therapeutics, Inc. Buy 11.95% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MRSN
Assets Removed
Asset Action Perf %
AMRX Sell All 3.8%
Assets Rebalanced
None
2023-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 9.69% 3.07%
ISRG Intuitive Surgical, Inc. Buy 9.86% 4.94%
RMD ResMed Inc. Buy 9.22% -1.86%
THC Tenet Healthcare Corporation Buy 10.18% 8.34%
AMRX Amneal Pharmaceuticals, Inc. Buy 12.6% 8.55%
CBAY CymaBay Therapeutics, Inc. Buy 9.37% 1.96%
SENS Senseonics Holdings, Inc. Buy 9.58% 4.22%
NVCR NovoCure Limited Buy 9.17% 0%
SGRY Surgery Partners, Inc. Buy 9.17% 0%
AMEH Apollo Medical Holdings, Inc. Buy 9.17% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
  • SGRY
  • AMEH
Assets Removed
None
Assets Rebalanced
None
2023-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 9.78% 1.21%
ISRG Intuitive Surgical, Inc. Buy 9.82% 1.65%
RMD ResMed Inc. Buy 9.2% -4.78%
THC Tenet Healthcare Corporation Buy 9.82% 1.69%
AMRX Amneal Pharmaceuticals, Inc. Buy 12.13% 1.66%
CBAY CymaBay Therapeutics, Inc. Buy 9.45% 0%
SENS Senseonics Holdings, Inc. Buy 9.45% 0%
The percentage of cash held in the portfolio is: 30.35%
New Assets Added
  • CBAY
  • SENS
Assets Removed
None
Assets Rebalanced
None
2023-11-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 9.9% 1.28%
ISRG Intuitive Surgical, Inc. Buy 9.57% -1.98%
RMD ResMed Inc. Buy 9.33% -4.45%
THC Tenet Healthcare Corporation Buy 9.53% -2.41%
AMRX Amneal Pharmaceuticals, Inc. Buy 11.89% -1.43%
The percentage of cash held in the portfolio is: 49.78%
New Assets Added
None
Assets Removed
Asset Action Perf %
EDIT Sell All 14.06%
SGRY Sell All 7.24%
VNDA Sell All -22.65%
Assets Rebalanced
None
2023-11-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 9.7% 3.78%
EDIT Editas Medicine, Inc. Buy 11.38% 21.74%
VNDA Vanda Pharmaceuticals Inc. Buy 9.27% -0.92%
ISRG Intuitive Surgical, Inc. Buy 9.35% 0.01%
RMD ResMed Inc. Buy 9.26% -0.88%
THC Tenet Healthcare Corporation Buy 9.46% 1.22%
SGRY Surgery Partners, Inc. Buy 10.71% 14.61%
AMRX Amneal Pharmaceuticals, Inc. Buy 11.14% -3.56%
The percentage of cash held in the portfolio is: 19.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -4.54%
SMMT Sell All -6.41%
Assets Rebalanced
None
2023-11-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
EW Edwards Lifesciences Corporation Buy 9.6% 5.12%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.45% 3.49%
EDIT Editas Medicine, Inc. Buy 10.99% 20.43%
SMMT Summit Therapeutics Inc. Buy 10.21% 11.79%
VNDA Vanda Pharmaceuticals Inc. Buy 9.32% 2.06%
ISRG Intuitive Surgical, Inc. Buy 9.1% -0.23%
RMD ResMed Inc. Buy 9.35% 2.52%
THC Tenet Healthcare Corporation Buy 9.23% 1.2%
SGRY Surgery Partners, Inc. Buy 9.48% 3.85%
AMRX Amneal Pharmaceuticals, Inc. Buy 11.27% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AMRX
Assets Removed
Asset Action Perf %
PODD Sell All 16.93%
Assets Rebalanced
None
2023-11-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.6% 3.33%
EW Edwards Lifesciences Corporation Buy 9.89% 2.66%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.48% -1.57%
EDIT Editas Medicine, Inc. Buy 9.81% 1.88%
SMMT Summit Therapeutics Inc. Buy 9.88% 2.56%
VNDA Vanda Pharmaceuticals Inc. Buy 9.85% 2.29%
ISRG Intuitive Surgical, Inc. Buy 9.62% 0%
RMD ResMed Inc. Buy 9.62% 0%
THC Tenet Healthcare Corporation Buy 9.62% 0%
SGRY Surgery Partners, Inc. Buy 9.62% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ISRG
  • RMD
  • THC
  • SGRY
Assets Removed
None
Assets Rebalanced
None
2023-11-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 10.5% 1.33%
EW Edwards Lifesciences Corporation Buy 9.72% 0%
BCRX BioCryst Pharmaceuticals, Inc. Buy 9.72% 0%
EDIT Editas Medicine, Inc. Buy 9.72% 0%
SMMT Summit Therapeutics Inc. Buy 9.72% 0%
VNDA Vanda Pharmaceuticals Inc. Buy 9.72% 0%
The percentage of cash held in the portfolio is: 40.89%
New Assets Added
  • EW
  • BCRX
  • EDIT
  • SMMT
  • VNDA
Assets Removed
Asset Action Perf %
MODV Sell All 21.73%
Assets Rebalanced
None
2023-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
MODV ModivCare Inc. Buy 12.27% 17.37%
PODD Insulet Corporation Buy 10.25% -1.82%
The percentage of cash held in the portfolio is: 77.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRTX Sell All -1.48%
CYTK Sell All 3.73%
Assets Rebalanced
None
2023-10-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.45% 0.18%
CYTK Cytokinetics, Incorporated Buy 11.05% 5.92%
MODV ModivCare Inc. Buy 11.96% 14.74%
PODD Insulet Corporation Buy 10.36% -0.57%
The percentage of cash held in the portfolio is: 56.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMRX Sell All -4.25%
MYGN Sell All -8.91%
Assets Rebalanced
None
2023-10-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.38% 0.67%
CYTK Cytokinetics, Incorporated Buy 10.98% 6.5%
MODV ModivCare Inc. Buy 12.02% 16.64%
PODD Insulet Corporation Buy 10.58% 2.74%
AMRX Amneal Pharmaceuticals, Inc. Buy 9.14% -2%
MYGN Myriad Genetics, Inc. Buy 8.79% -5.83%
The percentage of cash held in the portfolio is: 38.11%
New Assets Added
None
Assets Removed
Asset Action Perf %
MRSN Sell All -22.92%
HAE Sell All -6.51%
STAA Sell All -11.44%
Assets Rebalanced
None
2023-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.09% 2.43%
CYTK Cytokinetics, Incorporated Buy 10.26% 4.12%
MODV ModivCare Inc. Buy 12.47% 26.62%
MRSN Mersana Therapeutics, Inc. Buy 9.07% -7.99%
PODD Insulet Corporation Buy 10.21% 3.75%
HAE Haemonetics Corporation Buy 9.51% -3.36%
STAA STAAR Surgical Company Buy 9.64% -2.08%
AMRX Amneal Pharmaceuticals, Inc. Buy 8.92% 0%
MYGN Myriad Genetics, Inc. Buy 8.92% 0%
The percentage of cash held in the portfolio is: 10.92%
New Assets Added
  • AMRX
  • MYGN
Assets Removed
None
Assets Rebalanced
None
2023-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 10.01% 1.95%
CYTK Cytokinetics, Incorporated Buy 10.23% 4.18%
MODV ModivCare Inc. Buy 11.74% 19.57%
MRSN Mersana Therapeutics, Inc. Buy 9.89% 0.69%
PODD Insulet Corporation Buy 10.61% 8.16%
HAE Haemonetics Corporation Buy 9.57% -2.4%
STAA STAAR Surgical Company Buy 9.31% -5.09%
The percentage of cash held in the portfolio is: 28.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -9.98%
ENTA Sell All -9.78%
Assets Rebalanced
None
2023-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 9.71% 0.34%
CYTK Cytokinetics, Incorporated Buy 10.47% 8.2%
MODV ModivCare Inc. Buy 11.84% 22.4%
MRSN Mersana Therapeutics, Inc. Buy 10.21% 5.56%
PODD Insulet Corporation Buy 10.29% 6.49%
NVCR NovoCure Limited Buy 9% -6.85%
HAE Haemonetics Corporation Buy 9.47% -2.01%
STAA STAAR Surgical Company Buy 9.21% -4.71%
ENTA Enanta Pharmaceuticals, Inc. Buy 8.96% -7.26%
The percentage of cash held in the portfolio is: 10.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
INGN Sell All -9.35%
Assets Rebalanced
None
2023-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 9.75% 3.57%
CYTK Cytokinetics, Incorporated Buy 10.88% 15.62%
MODV ModivCare Inc. Buy 10.69% 13.63%
MRSN Mersana Therapeutics, Inc. Buy 9.93% 5.56%
PODD Insulet Corporation Buy 9.78% 4.02%
NVCR NovoCure Limited Buy 9.4% 0%
HAE Haemonetics Corporation Buy 9.4% 0%
STAA STAAR Surgical Company Buy 9.4% 0%
INGN Inogen, Inc. Buy 9.4% 0%
ENTA Enanta Pharmaceuticals, Inc. Buy 9.4% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NVCR
  • HAE
  • STAA
  • INGN
  • ENTA
Assets Removed
None
Assets Rebalanced
None
2023-10-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 9.79% 3.71%
CYTK Cytokinetics, Incorporated Buy 10.69% 13.24%
MODV ModivCare Inc. Buy 10.1% 7.11%
MRSN Mersana Therapeutics, Inc. Buy 10.88% 15.28%
PODD Insulet Corporation Buy 9.43% 0%
The percentage of cash held in the portfolio is: 49.12%
New Assets Added
  • PODD
Assets Removed
None
Assets Rebalanced
None
2023-10-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 9.92% 2.05%
CYTK Cytokinetics, Incorporated Buy 10.6% 9.12%
MODV ModivCare Inc. Buy 9.48% -2.43%
MRSN Mersana Therapeutics, Inc. Buy 9.72% 0%
The percentage of cash held in the portfolio is: 60.29%
New Assets Added
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2023-10-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 9.75% 1.28%
CYTK Cytokinetics, Incorporated Buy 11.31% 17.48%
MODV ModivCare Inc. Buy 9.62% 0%
The percentage of cash held in the portfolio is: 69.33%
New Assets Added
  • MODV
Assets Removed
None
Assets Rebalanced
None
2023-10-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
VRTX Vertex Pharmaceuticals Incorporated Buy 9.8% 0%
CYTK Cytokinetics, Incorporated Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • VRTX
  • CYTK
Assets Removed
None
Assets Rebalanced
None
2023-09-29 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CNC Sell All 4.24%
Assets Rebalanced
None
2023-09-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
CNC Centene Corporation Buy 11.15% 4.97%
The percentage of cash held in the portfolio is: 88.85%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All 9%
Assets Rebalanced
None
2023-09-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 11.66% 6.71%
CNC Centene Corporation Buy 11.21% 5.34%
The percentage of cash held in the portfolio is: 77.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
IBRX Sell All -18.33%
Assets Rebalanced
None
2023-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 11.51% 6.26%
CNC Centene Corporation Buy 11.21% 6.22%
IBRX ImmunityBio, Inc. Buy 9.06% -10.56%
The percentage of cash held in the portfolio is: 68.22%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDXS Sell All -14.77%
Assets Rebalanced
None
2023-09-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 11.23% 4.1%
CNC Centene Corporation Buy 11% 4.67%
CDXS Codexis, Inc. Buy 9.62% -8.52%
IBRX ImmunityBio, Inc. Buy 9.16% -9.17%
The percentage of cash held in the portfolio is: 58.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
IOVA Sell All -15.01%
Assets Rebalanced
None
2023-09-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 10.96% 2.34%
CNC Centene Corporation Buy 10.7% 2.47%
CDXS Codexis, Inc. Buy 10.09% -3.41%
IBRX ImmunityBio, Inc. Buy 9.32% -6.94%
IOVA Iovance Biotherapeutics, Inc. Buy 8.92% -11.47%
The percentage of cash held in the portfolio is: 50.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
IMGN Sell All -8.1%
BHVN Sell All -12.29%
ICPT Sell All -8.77%
Assets Rebalanced
None
2023-09-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 10.48% -1.63%
HQY HealthEquity, Inc. Buy 10.68% 2.31%
CNC Centene Corporation Buy 10.38% 2.12%
BHVN Biohaven Ltd. Buy 9.45% -7.1%
CDXS Codexis, Inc. Buy 10.11% -0.57%
ICPT Intercept Pharmaceuticals, Inc. Buy 9.49% -6.75%
IBRX ImmunityBio, Inc. Buy 9.71% -0.56%
IOVA Iovance Biotherapeutics, Inc. Buy 8.99% -8.43%
The percentage of cash held in the portfolio is: 20.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
AMEH Sell All -4.94%
STAA Sell All -7.33%
Assets Rebalanced
None
2023-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 10.42% -1.38%
HQY HealthEquity, Inc. Buy 10.12% -2.22%
CNC Centene Corporation Buy 10.3% 2.14%
BHVN Biohaven Ltd. Buy 9.48% -6.02%
STAA STAAR Surgical Company Buy 9.5% -5.83%
CDXS Codexis, Inc. Buy 10.38% 2.84%
ICPT Intercept Pharmaceuticals, Inc. Buy 9.65% -4.47%
AMEH Apollo Medical Holdings, Inc. Buy 9.43% -2.58%
IBRX ImmunityBio, Inc. Buy 8.98% -7.22%
IOVA Iovance Biotherapeutics, Inc. Buy 9.74% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IOVA
Assets Removed
None
Assets Rebalanced
None
2023-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IMGN ImmunoGen, Inc. Buy 10.15% -1.32%
HQY HealthEquity, Inc. Buy 10.03% -0.46%
CNC Centene Corporation Buy 10.02% 2.06%
BHVN Biohaven Ltd. Buy 9.64% -1.8%
STAA STAAR Surgical Company Buy 9.55% -2.8%
CDXS Codexis, Inc. Buy 10.83% 10.23%
ICPT Intercept Pharmaceuticals, Inc. Buy 9.49% -3.46%
AMEH Apollo Medical Holdings, Inc. Buy 9.43% 0%
IBRX ImmunityBio, Inc. Buy 9.43% 0%
The percentage of cash held in the portfolio is: 11.43%
New Assets Added
  • AMEH
  • IBRX
Assets Removed
Asset Action Perf %
ATXS Sell All -9.49%
VERU Sell All -9.09%
DXCM Sell All -6.84%
Assets Rebalanced
None
2023-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 9.9% -2.51%
IMGN ImmunoGen, Inc. Buy 9.84% -3.01%
VERU Veru Inc. Buy 9.41% -7.27%
DXCM DexCom, Inc. Buy 10.29% 1.39%
HQY HealthEquity, Inc. Buy 10.12% 1.8%
CNC Centene Corporation Buy 9.77% 0.87%
BHVN Biohaven Ltd. Buy 9.57% -1.23%
STAA STAAR Surgical Company Buy 9.75% 0.65%
CDXS Codexis, Inc. Buy 9.64% -0.57%
ICPT Intercept Pharmaceuticals, Inc. Buy 9.7% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ICPT
Assets Removed
None
Assets Rebalanced
None
2023-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 9.94% -1.71%
IMGN ImmunoGen, Inc. Buy 9.95% -1.63%
VERU Veru Inc. Buy 9.66% -4.55%
DXCM DexCom, Inc. Buy 10.5% 3.74%
HQY HealthEquity, Inc. Buy 10.01% 0.99%
CNC Centene Corporation Buy 9.65% -0.03%
BHVN Biohaven Ltd. Buy 9.3% -3.7%
STAA STAAR Surgical Company Buy 9.66% 0%
CDXS Codexis, Inc. Buy 9.66% 0%
The percentage of cash held in the portfolio is: 11.66%
New Assets Added
  • STAA
  • CDXS
Assets Removed
None
Assets Rebalanced
None
2023-09-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 10.33% 2.63%
IMGN ImmunoGen, Inc. Buy 9.78% -2.76%
VERU Veru Inc. Buy 9.51% -5.45%
DXCM DexCom, Inc. Buy 10.21% 1.44%
HQY HealthEquity, Inc. Buy 10.15% 2.93%
CNC Centene Corporation Buy 9.6% 0%
BHVN Biohaven Ltd. Buy 9.6% 0%
The percentage of cash held in the portfolio is: 30.81%
New Assets Added
  • CNC
  • BHVN
Assets Removed
Asset Action Perf %
ESPR Sell All -14.72%
Assets Rebalanced
None
2023-09-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 10.23% 1.94%
ESPR Esperion Therapeutics, Inc. Buy 8.86% -11.66%
IMGN ImmunoGen, Inc. Buy 9.82% -2.13%
VERU Veru Inc. Buy 9.58% -4.55%
DXCM DexCom, Inc. Buy 10.37% 3.35%
HQY HealthEquity, Inc. Buy 9.83% 0%
The percentage of cash held in the portfolio is: 41.32%
New Assets Added
  • HQY
Assets Removed
None
Assets Rebalanced
None
2023-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 10.13% 0.69%
ESPR Esperion Therapeutics, Inc. Buy 9.07% -9.82%
IMGN ImmunoGen, Inc. Buy 9.77% -2.95%
VERU Veru Inc. Buy 9.97% -0.91%
DXCM DexCom, Inc. Buy 9.76% -2.99%
The percentage of cash held in the portfolio is: 51.3%
New Assets Added
None
Assets Removed
Asset Action Perf %
IONS Sell All -3.72%
Assets Rebalanced
None
2023-09-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 10.14% 1.71%
IONS Ionis Pharmaceuticals, Inc. Buy 9.82% -1.44%
ESPR Esperion Therapeutics, Inc. Buy 9.78% -1.84%
IMGN ImmunoGen, Inc. Buy 9.91% -0.56%
VERU Veru Inc. Buy 9.42% -5.45%
DXCM DexCom, Inc. Buy 9.73% -2.36%
The percentage of cash held in the portfolio is: 41.21%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRMD Sell All -6.89%
Assets Rebalanced
None
2023-08-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 10.07% 2.74%
IONS Ionis Pharmaceuticals, Inc. Buy 9.73% -0.71%
ESPR Esperion Therapeutics, Inc. Buy 9.62% -1.84%
IRMD IRadimed Corporation Buy 9.8% 0%
IMGN ImmunoGen, Inc. Buy 9.8% 0%
VERU Veru Inc. Buy 9.8% 0%
DXCM DexCom, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 31.39%
New Assets Added
  • IRMD
  • IMGN
  • VERU
  • DXCM
Assets Removed
None
Assets Rebalanced
None
2023-08-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 9.85% 0.57%
IONS Ionis Pharmaceuticals, Inc. Buy 9.84% 0.49%
ESPR Esperion Therapeutics, Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.53%
New Assets Added
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2023-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATXS Astria Therapeutics, Inc. Buy 9.8% 0%
IONS Ionis Pharmaceuticals, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 80.4%
New Assets Added
  • ATXS
  • IONS
Assets Removed
None
Assets Rebalanced
None
2023-08-22 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All 2.77%
Assets Rebalanced
None
2023-08-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 10.61% -1.24%
The percentage of cash held in the portfolio is: 89.39%
New Assets Added
None
Assets Removed
Asset Action Perf %
INSM Sell All -1.81%
Assets Rebalanced
None
2023-08-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 10.87% 1.87%
INSM Insmed Incorporated Buy 10.87% 1.36%
The percentage of cash held in the portfolio is: 78.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
ILMN Sell All -5.25%
Assets Rebalanced
None
2023-08-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
ILMN Illumina, Inc. Buy 10.38% -2.82%
HQY HealthEquity, Inc. Buy 10.5% -1.62%
INSM Insmed Incorporated Buy 11.01% 2.67%
The percentage of cash held in the portfolio is: 68.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -16.1%
Assets Rebalanced
None
2023-08-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
ILMN Illumina, Inc. Buy 10.42% -1.48%
HQY HealthEquity, Inc. Buy 10.42% -1.43%
PDSB PDS Biotechnology Corporation Buy 10.02% -5.16%
INSM Insmed Incorporated Buy 10.55% -0.63%
The percentage of cash held in the portfolio is: 58.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
SNDX Sell All -8.65%
ALGN Sell All -6.2%
Assets Rebalanced
None
2023-08-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 9.87% -5.92%
ILMN Illumina, Inc. Buy 10.13% -2.7%
ALGN Align Technology, Inc. Buy 9.89% -4.95%
HQY HealthEquity, Inc. Buy 10.65% 2.46%
PDSB PDS Biotechnology Corporation Buy 10.68% 2.71%
INSM Insmed Incorporated Buy 10.46% 0.09%
The percentage of cash held in the portfolio is: 38.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Sell All -5.15%
Assets Rebalanced
None
2023-08-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 10.01% -5.32%
ILMN Illumina, Inc. Buy 10.43% -0.49%
ALGN Align Technology, Inc. Buy 9.99% -4.65%
ICUI ICU Medical, Inc. Buy 10.08% -3.75%
HQY HealthEquity, Inc. Buy 10.42% -0.44%
PDSB PDS Biotechnology Corporation Buy 10.08% -3.76%
INSM Insmed Incorporated Buy 10.35% -1.63%
The percentage of cash held in the portfolio is: 28.65%
New Assets Added
None
Assets Removed
Asset Action Perf %
NSTG Sell All -14.89%
NVRO Sell All -19.73%
TDOC Sell All -11.76%
Assets Rebalanced
None
2023-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 9.85% -2.36%
ILMN Illumina, Inc. Buy 9.93% -0.63%
ALGN Align Technology, Inc. Buy 9.77% -2.26%
NSTG NanoString Technologies, Inc. Buy 9.57% -4.22%
ICUI ICU Medical, Inc. Buy 9.79% -1.95%
TDOC Teladoc Health, Inc. Buy 9.31% -6.79%
HQY HealthEquity, Inc. Buy 9.94% -0.53%
NVRO Nevro Corp. Buy 9.86% -1.28%
PDSB PDS Biotechnology Corporation Buy 9.95% -0.44%
INSM Insmed Incorporated Buy 10.04% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • INSM
Assets Removed
None
Assets Rebalanced
None
2023-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 9.71% -1.43%
ILMN Illumina, Inc. Buy 9.85% 0.87%
ALGN Align Technology, Inc. Buy 9.57% -1.93%
NSTG NanoString Technologies, Inc. Buy 10.32% 5.78%
ICUI ICU Medical, Inc. Buy 9.76% 0%
TDOC Teladoc Health, Inc. Buy 9.76% 0%
HQY HealthEquity, Inc. Buy 9.76% 0%
NVRO Nevro Corp. Buy 9.76% 0%
PDSB PDS Biotechnology Corporation Buy 9.76% 0%
The percentage of cash held in the portfolio is: 11.76%
New Assets Added
  • ICUI
  • TDOC
  • HQY
  • NVRO
  • PDSB
Assets Removed
None
Assets Rebalanced
None
2023-07-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 9.75% -1.53%
ILMN Illumina, Inc. Buy 9.78% -0.41%
ALGN Align Technology, Inc. Buy 9.81% 0%
NSTG NanoString Technologies, Inc. Buy 9.81% 0%
The percentage of cash held in the portfolio is: 60.86%
New Assets Added
  • ALGN
  • NSTG
Assets Removed
None
Assets Rebalanced
None
2023-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 9.9% 0.14%
ILMN Illumina, Inc. Buy 9.74% -0.6%
The percentage of cash held in the portfolio is: 80.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
HROW Sell All -1.39%
Assets Rebalanced
None
2023-07-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 9.7% -1.71%
HROW Harrow Health, Inc. Buy 9.98% 1.07%
ILMN Illumina, Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.53%
New Assets Added
  • ILMN
Assets Removed
Asset Action Perf %
SEM Sell All -1.97%
Assets Rebalanced
None
2023-07-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 9.75% -1.2%
HROW Harrow Health, Inc. Buy 9.76% -1.11%
SEM Select Medical Holdings Corporation Buy 9.81% 0%
The percentage of cash held in the portfolio is: 70.68%
New Assets Added
  • SEM
Assets Removed
Asset Action Perf %
IBRX Sell All -4.93%
Assets Rebalanced
None
2023-07-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 9.97% 1.97%
SNDX Syndax Pharmaceuticals, Inc. Buy 9.83% 0.55%
HROW Harrow Health, Inc. Buy 9.78% 0%
The percentage of cash held in the portfolio is: 70.43%
New Assets Added
  • HROW
Assets Removed
None
Assets Rebalanced
None
2023-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 9.6% -2.3%
SNDX Syndax Pharmaceuticals, Inc. Buy 9.82% 0%
The percentage of cash held in the portfolio is: 80.58%
New Assets Added
  • SNDX
Assets Removed
None
Assets Rebalanced
None
2023-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IBRX ImmunityBio, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • IBRX
Assets Removed
Asset Action Perf %
NKTR Sell All -8.33%
Assets Rebalanced
None
2023-07-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 9.27% -5%
The percentage of cash held in the portfolio is: 90.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
MDXG Sell All 6.06%
Assets Rebalanced
None
2023-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDXG MiMedx Group, Inc. Buy 10.7% 4.63%
NKTR Nektar Therapeutics Buy 8.99% -8.33%
The percentage of cash held in the portfolio is: 80.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
HUM Sell All -5.76%
Assets Rebalanced
None
2023-07-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
MDXG MiMedx Group, Inc. Buy 10.68% 5.42%
HUM Humana Inc. Buy 9.74% -2.04%
NKTR Nektar Therapeutics Buy 9.39% -3.33%
The percentage of cash held in the portfolio is: 70.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All -15.6%
Assets Rebalanced
None
2023-06-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 9.07% -10.4%
MDXG MiMedx Group, Inc. Buy 10.33% 2.07%
HUM Humana Inc. Buy 9.7% -2.3%
NKTR Nektar Therapeutics Buy 9.38% -3.33%
The percentage of cash held in the portfolio is: 61.53%
New Assets Added
None
Assets Removed
Asset Action Perf %
EBS Sell All -9.73%
MCRB Sell All -6.43%
RGNX Sell All -2.04%
VERU Sell All -0.88%
Assets Rebalanced
None
2023-06-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.73% -8.36%
VERU Veru Inc. Buy 9.68% -8.85%
MCRB Seres Therapeutics, Inc. Buy 10.18% -3.57%
EBS Emergent BioSolutions Inc. Buy 10% -0.86%
NUTX Nutex Health Inc. Buy 9.62% -4.4%
MDXG MiMedx Group, Inc. Buy 10.19% 1.28%
HUM Humana Inc. Buy 9.65% -2.2%
NKTR Nektar Therapeutics Buy 9.65% 0%
The percentage of cash held in the portfolio is: 21.29%
New Assets Added
  • NKTR
Assets Removed
Asset Action Perf %
SMMT Sell All 0.41%
Assets Rebalanced
None
2023-06-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.84% -5.97%
VERU Veru Inc. Buy 10.47% 0%
MCRB Seres Therapeutics, Inc. Buy 9.85% -5.36%
SMMT Summit Therapeutics Inc. Buy 10.71% 7.72%
EBS Emergent BioSolutions Inc. Buy 9.91% -0.32%
NUTX Nutex Health Inc. Buy 8.99% -9.4%
MDXG MiMedx Group, Inc. Buy 10.21% 2.87%
HUM Humana Inc. Buy 9.51% -2.3%
The percentage of cash held in the portfolio is: 20.52%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -13.77%
Assets Rebalanced
None
2023-06-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.73% -3.88%
VERU Veru Inc. Buy 10.48% 3.54%
MCRB Seres Therapeutics, Inc. Buy 9.81% -2.5%
FATE Fate Therapeutics, Inc. Buy 8.85% -9.47%
SMMT Summit Therapeutics Inc. Buy 10.86% 13.01%
EBS Emergent BioSolutions Inc. Buy 9.87% 2.67%
NUTX Nutex Health Inc. Buy 9.84% 2.6%
MDXG MiMedx Group, Inc. Buy 9.74% 1.59%
HUM Humana Inc. Buy 9.41% 0%
The percentage of cash held in the portfolio is: 11.41%
New Assets Added
  • HUM
Assets Removed
Asset Action Perf %
CDXS Sell All -4.84%
OFIX Sell All -3.3%
Assets Rebalanced
None
2023-06-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.48% -3.83%
VERU Veru Inc. Buy 10.56% 7.08%
MCRB Seres Therapeutics, Inc. Buy 10.01% 2.14%
CDXS Codexis, Inc. Buy 9.79% 2.77%
FATE Fate Therapeutics, Inc. Buy 9.49% -0.34%
OFIX Orthofix Medical Inc. Buy 9.53% -0.05%
SMMT Summit Therapeutics Inc. Buy 10.69% 14.23%
EBS Emergent BioSolutions Inc. Buy 9.74% 4.06%
NUTX Nutex Health Inc. Buy 9.35% 0%
MDXG MiMedx Group, Inc. Buy 9.35% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • NUTX
  • MDXG
Assets Removed
None
Assets Rebalanced
None
2023-06-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 10.13% 0.9%
VERU Veru Inc. Buy 10.83% 7.96%
MCRB Seres Therapeutics, Inc. Buy 9.57% -4.11%
CDXS Codexis, Inc. Buy 9.86% 1.73%
FATE Fate Therapeutics, Inc. Buy 9.79% 1.03%
OFIX Orthofix Medical Inc. Buy 9.72% 0.15%
SMMT Summit Therapeutics Inc. Buy 9.53% 0%
EBS Emergent BioSolutions Inc. Buy 9.53% 0%
The percentage of cash held in the portfolio is: 21.05%
New Assets Added
  • SMMT
  • EBS
Assets Removed
Asset Action Perf %
NVAX Sell All -7.09%
Assets Rebalanced
None
2023-06-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.94% -1.09%
VERU Veru Inc. Buy 10.93% 8.85%
MCRB Seres Therapeutics, Inc. Buy 9.59% -3.93%
CDXS Codexis, Inc. Buy 9.67% -0.35%
NVAX Novavax, Inc. Buy 9.7% 0%
FATE Fate Therapeutics, Inc. Buy 9.32% -3.96%
OFIX Orthofix Medical Inc. Buy 9.71% 0%
The percentage of cash held in the portfolio is: 31.14%
New Assets Added
  • OFIX
Assets Removed
None
Assets Rebalanced
None
2023-06-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.67% -2.24%
VERU Veru Inc. Buy 11.47% 15.93%
MCRB Seres Therapeutics, Inc. Buy 10.04% 2.14%
CDXS Codexis, Inc. Buy 9.48% -0.69%
NVAX Novavax, Inc. Buy 9.57% 0.25%
FATE Fate Therapeutics, Inc. Buy 9.55% 0%
The percentage of cash held in the portfolio is: 40.22%
New Assets Added
  • FATE
Assets Removed
None
Assets Rebalanced
None
2023-06-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.83% 0.65%
VERU Veru Inc. Buy 11.41% 16.81%
MCRB Seres Therapeutics, Inc. Buy 10.73% 10.54%
CDXS Codexis, Inc. Buy 9.43% 0%
NVAX Novavax, Inc. Buy 9.43% 0%
The percentage of cash held in the portfolio is: 49.16%
New Assets Added
  • CDXS
  • NVAX
Assets Removed
Asset Action Perf %
INGN Sell All -9.41%
Assets Rebalanced
None
2023-06-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.83% 0%
VERU Veru Inc. Buy 11.4% 15.93%
INGN Inogen, Inc. Buy 9.12% -7.17%
MCRB Seres Therapeutics, Inc. Buy 10.1% 3.39%
The percentage of cash held in the portfolio is: 59.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -11.78%
Assets Rebalanced
None
2023-06-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
FATE Fate Therapeutics, Inc. Buy 9.36% -3.99%
RGNX REGENXBIO Inc. Buy 9.82% 0.7%
VERU Veru Inc. Buy 11.31% 15.93%
INGN Inogen, Inc. Buy 9.33% -4.3%
MCRB Seres Therapeutics, Inc. Buy 9.7% 0%
The percentage of cash held in the portfolio is: 50.48%
New Assets Added
  • MCRB
Assets Removed
Asset Action Perf %
HQY Sell All -3.49%
Assets Rebalanced
None
2023-06-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 9.68% -0.44%
FATE Fate Therapeutics, Inc. Buy 9.64% -0.91%
RGNX REGENXBIO Inc. Buy 9.84% 1.19%
VERU Veru Inc. Buy 10.5% 7.96%
INGN Inogen, Inc. Buy 9.72% 0%
The percentage of cash held in the portfolio is: 50.62%
New Assets Added
  • INGN
Assets Removed
None
Assets Rebalanced
None
2023-06-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 9.8% 0%
FATE Fate Therapeutics, Inc. Buy 9.8% 0%
RGNX REGENXBIO Inc. Buy 9.8% 0%
VERU Veru Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 60.8%
New Assets Added
  • HQY
  • FATE
  • RGNX
  • VERU
Assets Removed
None
Assets Rebalanced
None
2023-05-17 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORMP Sell All 58.78%
BMRN Sell All -5.11%
Assets Rebalanced
None
2023-05-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORMP Oramed Pharmaceuticals Inc. Buy 10.81% 11.43%
BMRN BioMarin Pharmaceutical Inc. Buy 9.55% -1.58%
The percentage of cash held in the portfolio is: 79.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGNX Sell All 2.73%
Assets Rebalanced
None
2023-05-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.93% 3.72%
ORMP Oramed Pharmaceuticals Inc. Buy 9.79% 0%
BMRN BioMarin Pharmaceutical Inc. Buy 9.79% 0%
The percentage of cash held in the portfolio is: 70.5%
New Assets Added
  • ORMP
  • BMRN
Assets Removed
None
Assets Rebalanced
None
2023-04-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
RGNX REGENXBIO Inc. Buy 9.17% -5.06%
The percentage of cash held in the portfolio is: 90.83%
New Assets Added
None
Assets Removed
Asset Action Perf %
MASI Sell All -4.78%
Assets Rebalanced
None
2023-04-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 9.57% -0.14%
RGNX REGENXBIO Inc. Buy 9.43% -1.6%
The percentage of cash held in the portfolio is: 81%
New Assets Added
None
Assets Removed
Asset Action Perf %
SGRY Sell All 17.06%
ALGN Sell All 6.28%
Assets Rebalanced
None
2023-04-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
SGRY Surgery Partners, Inc. Buy 9.97% 7.02%
ALGN Align Technology, Inc. Buy 9.7% 4.06%
MASI Masimo Corporation Buy 9.49% -2.08%
RGNX REGENXBIO Inc. Buy 9.68% -0.15%
The percentage of cash held in the portfolio is: 61.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPSI Sell All -0.74%
Assets Rebalanced
None
2023-04-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
CPSI Computer Programs and Systems, Inc. Buy 9.23% -1.41%
SGRY Surgery Partners, Inc. Buy 10.02% 7.08%
ALGN Align Technology, Inc. Buy 9.59% 2.43%
MASI Masimo Corporation Buy 9.51% -2.36%
RGNX REGENXBIO Inc. Buy 9.53% -2.17%
The percentage of cash held in the portfolio is: 52.12%
New Assets Added
None
Assets Removed
Asset Action Perf %
HROW Sell All 19.11%
Assets Rebalanced
None
2023-04-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
HROW Harrow Health, Inc. Buy 11.17% 20.14%
CPSI Computer Programs and Systems, Inc. Buy 9.39% 1.04%
SGRY Surgery Partners, Inc. Buy 9.96% 7.25%
ALGN Align Technology, Inc. Buy 9.49% 2.16%
MASI Masimo Corporation Buy 9.66% 0%
RGNX REGENXBIO Inc. Buy 9.66% 0%
The percentage of cash held in the portfolio is: 40.66%
New Assets Added
  • MASI
  • RGNX
Assets Removed
Asset Action Perf %
PACB Sell All 24.35%
Assets Rebalanced
None
2023-04-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
PACB Pacific Biosciences of California, Inc. Buy 11.8% 25.32%
HROW Harrow Health, Inc. Buy 10.81% 14.88%
CPSI Computer Programs and Systems, Inc. Buy 9.57% 1.72%
SGRY Surgery Partners, Inc. Buy 9.4% 0%
ALGN Align Technology, Inc. Buy 9.4% 0%
The percentage of cash held in the portfolio is: 49.01%
New Assets Added
  • SGRY
  • ALGN
Assets Removed
None
Assets Rebalanced
None
2023-03-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
PACB Pacific Biosciences of California, Inc. Buy 9.72% 0.87%
HROW Harrow Health, Inc. Buy 11.23% 16.5%
CPSI Computer Programs and Systems, Inc. Buy 9.63% 0%
The percentage of cash held in the portfolio is: 69.42%
New Assets Added
  • CPSI
Assets Removed
None
Assets Rebalanced
None
2023-03-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
PACB Pacific Biosciences of California, Inc. Buy 10.15% 4%
HROW Harrow Health, Inc. Buy 9.76% 0%
The percentage of cash held in the portfolio is: 80.09%
New Assets Added
  • HROW
Assets Removed
None
Assets Rebalanced
None
2023-03-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
PACB Pacific Biosciences of California, Inc. Buy 9.8% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • PACB
Assets Removed
None
Assets Rebalanced
None
2023-03-01 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
HQY Sell All 4.41%
Assets Rebalanced
None
2023-02-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
HQY HealthEquity, Inc. Buy 10.43% 4.57%
The percentage of cash held in the portfolio is: 89.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All 18.55%
Assets Rebalanced
None
2023-02-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ALDX Aldeyra Therapeutics, Inc. Buy 11.33% 11.94%
HQY HealthEquity, Inc. Buy 10.5% 4.61%
The percentage of cash held in the portfolio is: 78.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
LMAT Sell All -0.17%
Assets Rebalanced
None
2023-02-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
LMAT LeMaitre Vascular, Inc. Buy 10.11% 4.15%
ALDX Aldeyra Therapeutics, Inc. Buy 11.52% 14.68%
HQY HealthEquity, Inc. Buy 10.54% 5.85%
The percentage of cash held in the portfolio is: 67.84%
New Assets Added
None
Assets Removed
Asset Action Perf %
DXCM Sell All 7.53%
Assets Rebalanced
None
2023-02-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
DXCM DexCom, Inc. Buy 8.94% 10.83%
LMAT LeMaitre Vascular, Inc. Buy 9.99% 0.99%
ALDX Aldeyra Therapeutics, Inc. Buy 10.32% 0.81%
HQY HealthEquity, Inc. Buy 10.27% 1.14%
The percentage of cash held in the portfolio is: 60.48%
New Assets Added
None
Assets Removed
Asset Action Perf %
SLP Sell All -2.07%
EXEL Sell All 3.94%
Assets Rebalanced
None
2023-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
SLP Simulations Plus, Inc. Buy 9.56% -2.99%
EXEL Exelixis, Inc. Buy 10.18% 3.29%
DXCM DexCom, Inc. Buy 8.21% 0.49%
LMAT LeMaitre Vascular, Inc. Buy 10.07% 0.58%
ALDX Aldeyra Therapeutics, Inc. Buy 10.74% 3.71%
HQY HealthEquity, Inc. Buy 9.93% -3.35%
The percentage of cash held in the portfolio is: 41.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
TNDM Sell All -8.36%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings